CWCF in­tro­duces app for can­cer man­age­ment

BioSpectrum (Asia) - - Regulatory News -

The Cher­ish Women’s Can­cer Foun­da­tion, a Bris­banebased char­ity, has launched a smart­phone app to help women with ovar­ian can­cer self-mon­i­tor their treat­ment and re­sults. The app is set to im­prove the lives of many Aus­tralian women who are di­ag­nosed with ovar­ian can­cer each year. Brain­child of lead­ing gy­nae­co­log­i­cal on­col­o­gist, re­searcher and Cher­ish co­founder Pro­fes­sor An­dreas Ober­mair, the CA-125 app will al­low women di­ag­nosed with ovar­ian can­cer to self-mon­i­tor their treat­ment and re­sults.

The app is named af­ter the CA125 pro­tein, which is pro­duced by ovar­ian can­cer cells and shed into the blood­stream where it can be de­tected. Com­monly re­ferred to as a ‘tu­mour marker’, CA-125 lev­els are mon­i­tored through reg­u­lar blood tests be­fore, dur­ing and af­ter treat­ment to track can­cer progress. Af­ter en­ter­ing their holis­tic med­i­cal treat­ment into the smart­phone app, pa­tients will be able to fol­low the trends be­tween their treat­ment (surgery, chemo­ther­apy and ra­di­a­tion) and tu­mour marker changes, and the sub­se­quent im­pact of var­i­ous life­style fac­tors on their can­cer test re­sults.

Newspapers in English

Newspapers from India

© PressReader. All rights reserved.